ストックスクリーナーアプリを入手
3.475
4.67%
0.155
プレマーケット:
3.64
0.165
+4.75%
前日終値:
$3.32
開ける：
$3.31
24時間の取引高:
768.47K
Relative Volume:
0.82
時価総額：
$133.66M
収益：
$210.70K
当期純損益:
$-21.37M
株価収益率:
-3.1591
EPS:
-1.1
ネットキャッシュフロー:
$-21.10M
1週間 パフォーマンス:
+10.67%
1か月 パフォーマンス:
+109.34%
6か月 パフォーマンス:
+74.62%
1年 パフォーマンス:
+88.86%
1日の値動き範囲:
$3.1724
$3.475
1週間の範囲:
$2.92
$3.6487
52週間の値動き範囲:
$1.41
$3.6487
Gain Therapeutics Inc Stock (GANX) Company Profile
GANX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
3.475 | 127.69M | 210.70K | -21.37M | -21.10M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2024-12-06 | 開始されました | ROTH MKM | Buy |
| 2024-08-14 | 再開されました | Oppenheimer | Outperform |
| 2021-04-12 | 開始されました | BTIG Research | Buy |
| 2021-04-12 | 開始されました | Oppenheimer | Outperform |
Gain Therapeutics Inc (GANX) 最新ニュース
Gain Therapeutics, Inc. (GANX) 5.14% in After-hours: What’s Driving the Move? - Stocks Telegraph
FY2025 Earnings Forecast for GANX Issued By HC Wainwright - MarketBeat
HC Wainwright Predicts Higher Earnings for Gain Therapeutics - Defense World
H.C. Wainwright reiterates Buy rating on Gain Therapeutics stock ahead of trial data By Investing.com - Investing.com South Africa
Gain Therapeutics Inc (GANX) expanding its growth trajectory ahead - Setenews
H.C. Wainwright reiterates Buy rating on Gain Therapeutics stock ahead of trial data - Investing.com India
Gain Therapeutics’ (GANX) Preclinical Momentum Drives Its Progress in Parkinson’s Drug Development - MSN
What drives Gain Therapeutics Inc stock priceGrowth vs. Value Investing & Low Cost Market Strategies - earlytimes.in
Gain Therapeutics files prospectus supplement for $35.5 million stock offering By Investing.com - Investing.com Australia
Gain Therapeutics' (GANX) Preclinical Momentum Drives Its Progress in Parkinson's Drug Development - Finviz
Gain Therapeutics Announces New Stock Offering Program - TipRanks
Gain Therapeutics files prospectus supplement for $35.5 million stock offering - Investing.com
Gain Therapeutics files prospectus for $35.5 million stock saleSEC filing - marketscreener.com
Gain Therapeutics Files Prospectus Supplement for Stock Offering - TradingView
Can Gain Therapeutics Inc. stock sustain institutional interestTrend Reversal & Smart Allocation Stock Reports - BỘ NỘI VỤ
12 Hot Penny Stocks to Invest in Right Now - Insider Monkey
Valuation Update: Why Gain Therapeutics Inc. stock could see breakout soonNew Guidance & Daily Technical Stock Forecast Reports - moha.gov.vn
A History of Outperforming Analyst Forecasts and Beating the Odds: Gain Therapeutics Inc (GANX) - Setenews
Gain Therapeutics Inc Stock Analysis and ForecastRisk-Reward Ratio Analysis & Rapid Wealth Building Tips - earlytimes.in
How Gain Therapeutics Inc. stock compares to industry benchmarksWeekly Profit Report & Expert Approved Trade Ideas - newser.com
Gain Therapeutics presents data on GT-02287 - TipRanks
Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025 - The Manila Times
Gain Therapeutics (Nasdaq: GANX) Reports GT-02287 Mitochondrial, Neuronal Data - Stock Titan
Will Gain Therapeutics Inc. stock deliver strong dividend growthInsider Buying & Real-Time Volume Analysis Alerts - newser.com
Gain Therapeutics Inc. stock outlook for YEARJuly 2025 Short Interest & Risk Controlled Swing Alerts - newser.com
Is Gain Therapeutics Inc. stock ready for a breakoutWeekly Trade Recap & Weekly Breakout Watchlists - newser.com
Can machine learning forecast Gain Therapeutics Inc. recovery2025 Performance Recap & Fast Momentum Entry Tips - newser.com
Gain Therapeutics (GANX) Upgraded to Buy: Here's What You Should Know - sharewise.com
How does Gain Therapeutics Inc (GANX) change from a tortoise to a hare? - Setenews
Is Gain Therapeutics Inc. stock undervalued vs historical averagesQuarterly Market Summary & Consistent Growth Stock Picks - newser.com
Equities Analysts Set Expectations for GANX FY2025 Earnings - Defense World
Will Gain Therapeutics Inc. stock go up soon2025 Price Targets & AI Enhanced Trading Signals - newser.com
Can Gain Therapeutics Inc. stock deliver sustainable ROEWeekly Trade Summary & AI Enhanced Trade Execution Alerts - newser.com
Why Gain Therapeutics Inc. stock remains on buy listsJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com
Is Gain Therapeutics Inc. stock a buy before product launchesMarket Trend Review & Safe Capital Preservation Plans - newser.com
Building trade automation scripts for Gain Therapeutics Inc.Weekly Trading Summary & Verified Momentum Watchlists - newser.com
Gain Therapeutics Inc (GANX) 財務データ
収益
当期純利益
現金流量
EPS
1.10%
1.10%
大文字化:
|
ボリューム (24 時間):